Chemiluminescence determination of chlorpheniramine using tris(1,10‐phenanthroline)–ruthenium(II) peroxydisulphate system and sequential injection analysis | Zendy

Suliman Fakhr Eldin O. | Zendy; AlHinai Mohammed M. | Zendy; AlKindy Salma M. Z. | Zendy; Salama Salama B. | Zendy

Premium

Chemiluminescence determination of chlorpheniramine using tris(1,10‐phenanthroline)–ruthenium(II) peroxydisulphate system and sequential injection analysis

Author(s) -

Suliman Fakhr Eldin O.,

AlHinai Mohammed M.,

AlKindy Salma M. Z.,

Salama Salama B.

Publication year - 2008

Publication title -

luminescence

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.428

H-Index - 45

eISSN - 1522-7243

pISSN - 1522-7235

DOI - 10.1002/bio.1054

Subject(s) - chemiluminescence , ruthenium , phenanthroline , tris , chemistry , chromatography , organic chemistry , biochemistry , catalysis

A sequential injection (SI) method was developed for the determination of chlorpheniramine (CPA), based on the reaction of this drug with tris(1,10‐phenanthroline)–ruthenium(II) [Ru(phen) 3 2+ ] and peroxydisulphate (S 2 O 8 2– ) in the presence of light. The instrumental set‐up utilized a syringe pump and a multiposition valve to aspirate the reagents [Ru(phen) 3 2+ and S 2 O 8 2– ] and a peristaltic pump to propel the sample. The experimental conditions affecting the chemiluminescence reaction were systematically optimized, using the univariate approach. Under the optimum conditions linear calibration curves of 0.1–10 µg/ml were obtained. The detection limit was 0.04 µg/ml and the relative standard deviation (RSD) was always < 5%. The procedure was applied to the analysis of CPA in pharmaceutical products and was found to be free from interferences from concomitants usually present in these preparations. Copyright © 2008 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research